Future of Chronic Hepatitis B Infection Therapies
Telemedicine Consult - Dr. Gish
Schedule Telemedicine Consult with Dr. Gish

Future of Chronic Hepatitis B Infection Therapies

Future of Chronic Hepatitis B Infection Therapies

Canocapavir (ZM-H1505R) is a small-molecule HBV capsid assembly modulator
(CAM) with a novel pyrazole structure1. This is the first-in-human (FIH) study to
investigate its safety, tolerability, and pharmacokinetics (PK) following oral
administration in healthy subjects.

Read Article


Metadata